Related Experiment Video
Updated: Nov 25, 2025
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Magnetic resonance imaging for evaluating tumor resectability in advanced ovarian cancer: A protocol for systematic
Ping Liu1, Lingli Deng1, Lijun Yang2
1Department of Radiology.
Background:
This study will evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) to investigate tumor resectability at primary debulking surgery among women experiencing advanced-stage ovarian cancer.
Methods:
We will systematically search the randomized controlled trials (RCTs) for potentially eligible studies from electronic databases, including 4 English databases (PubMed, EMBASE, Web of Science, and Cochrane Library) and 3 Chinese databases (China National Knowledge Infrastructure, WanFang, and China Biomedical Database). The study language will be restricted to English and Chinese. Also, 2 independent authors will collect and carry out data extraction as well as quality assessment. Data will be synthesized using appropriate statistical methods.
Results:
We will summarize present study's evidence to assess the diagnostic accuracy of MRI for evaluating tumor resectability at primary debulking surgery in women experiencing advanced-stage ovarian cancer.
Conclusion:
The present study will put forward the latest high-quality evidence for MRI's clinical application for evaluating tumor resectability in women experiencing advanced ovarian cancer.
Ethics And Dissemination:
Since the present study is a systematic review and meta-analysis based on the published literature, ethical approval will not be necessary.
Protocol Registration Number:
DOI 10.17605/OSF.IO/UWDRF (https://osf.io/uwdrf/).
